medic suppli devic
reason report
bottom line follow upgrad ew link
review recent investor feedback rate chang offer
increment consider light feedback amongst least
investor spoken last day
seem get pushback vs support call
whole feel like investor agre ew good long-term best-
in-class growth stori question price sens
lack visibl extent speed recoveri
made investor cautiou share recent late-march
covid low investor feel increment move
limit seemingli skew toward
pushback also didnt hear resist point wouldnt
anticip alreadi part commonplac bull/
bear debat around name provid select quot
pushback receiv well view issu question
tavr patient lost especi low risk
indic patient highest risk covid
current sit sidelin true major tavr
transcathet aortic valv replac patient age
thu high risk covid even low risk patient
sick sever symptomat aortic stenosi patient suffer
symptom like chest pain short breath patient
-- even low risk patient -- also high mortal rate
year treat risk mere design
patient mortal risk undergo open heart surgeri
mean less sick less symptomat base medacorp
physician convers last week tavr survey
link consist feedback got patient
eventu treat give us level confid
patient ultim come back hospit and/or enter referr
funnel like sooner rather later symptom also
import note certainli number covid hot
spot also mani region
covid case perhap fear less substanti albeit like
hospit priorit tavr procedur
patient requir least one two overnight stay
profit certainli fair tavr break-even -- best --
hospit wherea procedur like orthoped even
surgic aortic valv replac highli profit also done
check medacorp hospit administr larg
confirm feedback got physician -- tavr high
prioriti procedur elect procedur restrict lift due
life-threaten natur diseas could dynam
outpati procedur restart earlier patient requir
overnight stay bed icu believ icu bed
start clear hospit abl manag covid patient
keep separ isol believ tavr top
pleas refer page import disclosur price chart analyst certif
list actual tend believ hospit favor tavr surgeri
-- least initi fear covid possibl wave
still percol -- ensur capac icu tavr patient
averag length stay least half surgeri
margin recov fast sale thu ep
estim high fair point meaning
adjust oper expens sale rather focus
revenu limit variabl model lower gm
heavili impact quarter -- -- perhap prior gm
oper margin estim were/ar aggress recoveri
necessarili believ dramat lag oper
margin vs sale recoveri acknowledg possibl even
prove true base view sale recoveri believ
updat consensu ep estim prove far
low even prove high
daniel antalffi certifi view express report accur reflect view part
compens directli relat specif recommend view contain report
rate price target histori edward lifesci corpor ew
leerink place market perform rate ew februari
creat bluematrix
price target appli price-to-earnings multipl ep estim pt assum stabl
multipl current ep estim well large-cap group averag
also think ew market-lead posit highli under-penetrated total address market
justifi premium valuat rel rest large-cap med-tech group mp op mp
risk valuat
risk includ inflect point intermedi risk adopt ramp neg competit clinic data and/or
competit launch delay faster-than-expect low risk asymptomat trial ramp earlier-than-
distribut ratings/invest bank servic ib
explan rate
outperform buy expect stock outperform benchmark next month
market perform hold/neutr expect stock perform line benchmark next
under-perform sell expect stock under-perform benchmark next month
degre out-performance under-perform requir warrant outperform under-perform
rate commensur risk profil compani
purpos definit relev benchmark issuer
market capit less billion issuer market
capit billion
inform includ limit price quot statist obtain sourc
believ reliabl repres accur complet reli
upon inform subject chang without notic inform intend institut
use offer sell solicit buy product inform relat
svb leerink llc firm offic director employe proprietari account affili may
posit long short secur refer report and/or relat secur time
time may increas decreas posit express view contrari contain report
firm research analyst salespeopl trader profession may provid oral written market
commentari trade strategi contrari opinion express report firm asset
manag group proprietari account may make invest decis inconsist
opinion express document past perform secur guarante predict futur
perform transact strategi describ herein may suitabl investor document may
reproduc circul without svb leerink written author addit inform avail
upon request contact editori depart svb leerink llc one feder street floor boston
firm employe research analyst receiv compens impact among
factor overal firm profit includ revenu among busi unit institut
equiti research invest bank research analyst howev compens specif
invest bank servic transact extent svb leerink research report referenc
materi either attach hereto inform compani includ price rate market
make statu price chart compens disclosur analyst certif etc avail http //
